Skip to main content

NanoDetection Technology, Three Academic Labs to Co-Develop Bird Flu Detector

NEW YORK (GenomeWeb News) - NanoDetection Technology and three academic research centers plan to develop an onsite avian influenza detection system, the company said today. 
 
The partners are the University of Tennessee Health Science Center, St. Jude Children’s Research Hospital, and Oak Ridge National Laboratory. 
 
The technology is based on a biochip that detects photons produced as a result of DNA hybridization or protein conjugation, which constitutes a “positive” result.
 
NanoDetection said the detector is “chemistry and sample agnostic,” meaning that the same biochip “can conduct multiple, simultaneous tests and can use most biological and environmental samples.”
 
NanoDetection Technology CEO Charlie Barnett said the detector’s test results would not require any sophisticated analysis.
 
Additional details were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.